Scope of temporary treatment of unrealised gains and losses measured at fair value through other comprehensive income in view of the COVID-19 pandemic
- Regulation
- Regulation (EU) No 575/2013 (CRR)
- Article
- 468, para. 1
- Topic
- Own funds
- Submitted by
- Individual
- Submitted
- 2022-09-26
Question
Background
Original source: European Banking Authority, Q&A ID 2022_6590
This Q&A is published by European Banking Authority and is non-binding. It does not constitute legal advice. Updated weekly from official ESA sources.
Similar Q&As
Prudential filter on unrealised gains and losses on governmental exposures and interaction with the IFRS 9 transitional arrangements
Answered 2021-05-07
Handling of unrealised gains/losses in Own Funds and Exposures
Answered 2015-03-06
Preferential risk weight for indirect sovereign exposures in the currency of another Member State
Answered 2024-01-12
Treatment of decreases of impairments in the calculation of the exposure value
Answered 2016-09-23
General and specific credit risk adjustments
Answered 2018-08-03
More Q&As on this topic
C01.00 - CIU deduction from own funds
Answered 2025-03-21
4.0 Reporting Framework - COREP_OF C02 Template
Answered 2025-03-21
Direct contributions to reserves from shareholders
Answered 2025-02-07
Permission to reduce AT1, Tier 2 or eligible liabilities instruments and deduction rules in the context of a liability management exercise without replacement.
Answered 2024-04-05
Treasury shares – how to report them in Own Funds and in the NSFR
Answered 2024-02-23
📋 Track EU financial regulation continuously
Forseti monitors EU financial regulation and delivers personalised alerts anchored to verified official sources.
14-day free trial. No credit card required.